Interestingly, we found that hypoxia was activated in CRCS1, and the immune checkpoint-related signature, Treg, M2 macrophage were also enriched, which suggested that targeted hypoxia in such a group could reactivate tumor immunity in such a subtype. Here, GALNT12 is linked to neoplasm.